Boom or bust? Analysts reveal what lies ahead for India Inc in FY27 amid Iran war

Indian businesses brace for 2026-27 with geopolitical tensions and AI reshaping industries. While core sectors show stability, policy shifts and costs pose challenges. Experts see opportunities for long-term growth. Banks anticipate margin recover...

ET Online

India Inc navigates a cautiously optimistic path in 2026-27 amid Iran war and other disruptions

In 2026‑27, India Inc faces elevated uncertainty, driven by geopolitical tensions such as the Iran war, global commodity volatility and the disruptive rise of AI platforms reshaping traditional business models. Predicting how various sectors will shape up in coming quarters, ET Intelligence Group (ETIG) as well as various brokerages and agencies suggest that while fundamentals across major industries remain broadly stable, near-term risks persist from policy shifts, input cost pressures and fluctuating demand.

Click here to track live developments on Iran war

Analysts highlight that structural growth drivers -- including credit expansion, domestic consumption and export opportunities -- continue to support medium-term resilience. At the same time, valuation pressures, regulatory scrutiny and macroeconomic headwinds could temper near-term earnings growth. Investment houses note selective opportunities for long-term accumulation, as some segments trade at attractive levels despite broader market volatility. Overall, corporate India is expected to navigate a cautiously optimistic path, balancing robust fundamentals with short-term uncertainties.


BANKS

The Indian banking sector is expected to see a gradual recovery in net interest margins (NIMs) in FY27 as deposit repricing gains traction after the RBI’s cumulative 125‑basis‑point rate cuts in 2025, as per ETIF. It notes that steady loan growth and generally healthy asset quality should support earnings growth, though lingering geopolitical tensions in West Asia could dampen credit demand. ETIG cites RBI data showing credit growth that slowed to 9.5% in June 2025, rebounded to 14.5% in the December quarter and moderated to around 14% in February, while deposit growth remained tepid, staying in the 11-12% range in the same period. Given the lag in deposit growth relative to credit, banks may face short‑term funding cost pressures as they compete for deposits. A benign interest‑rate backdrop, pickup in private capex and improving consumption aided by GST rationalisation are expected to provide further support to credit demand in FY27.

Moody’s Ratings has projected that banks will maintain stability through FY27, underpinned by robust credit demand, improved asset quality, and prudent regulatory oversight. Similarly, Fitch Ratings highlights that the sector is on a stronger footing due to recent regulatory reforms and reduced systemic risks, which are expected to support continued growth opportunities. Complementing these ratings agency perspectives, brokerage analysts from Motilal Oswal and JP Morgan note that the sector is poised for a growth upswing, driven by lower funding costs, rising credit demand, and generally robust fundamentals.

Also Read: More missiles or no war? How markets are reading Trump's latest signals
ADVERTISEMENT

However, the sector is not without near-term headwinds. Jefferies notes that recent RBI tightening of forex derivative rules could impact sector-wide profitability and risk positions, highlighting potential pressures despite overall strong fundamentals. The integrated outlook suggests that while the Indian banking sector is fundamentally stable and positioned for growth, regulatory shifts and macroprudential measures warrant careful monitoring in the near term.

FMCG

The fast-moving consumer goods (FMCG) sector is likely to see improved earnings visibility in FY27, driven by stabilising raw material costs and cooling prices of several key agri-commodities, as per ETIG. It notes that a stronger summer demand compared with the previous year’s subdued consumption should further support growth.

Companies may implement selective price increases, particularly in categories where GST-led price reductions had previously compressed margins, while packaged foods and beauty & personal care segments are expected to sustain volume momentum thanks to lower effective prices. In the edible oils segment, ETIG highlights that past elevated product prices weighed on revenue growth, but with prices normalising and ongoing category premiumisation, players like Marico are expected to return to a growth trajectory. AWL Agri Business (formerly Adani Wilmar) has guided for single-digit growth, and soft copra prices, currently nearly 30% below peak, could further support the hair oil segment.

Also Read: Iran war knocks on boardrooms: Corporates stare at a new risk
ADVERTISEMENT

ETIG also flags risks from higher petroleum prices, which could increase packaging and logistics costs, and notes that an early onset of summer could boost demand for room air conditioners, potentially extending the season. Overall, the sector’s growth for FY27 is pegged at 45–50%, though pricing pressures are likely to persist as GST-cut benefits are partially offset by rising costs of copper, crude-linked plastics, and compliance with new BEE norms.

The sector is generally viewed by market analysts as poised for a gradual recovery and stronger performance in FY27, supported by volume improvements, premiumisation trends and strategic market share gains, even as macro pressures persist. Market strategist Abneesh Roy of Nuvama Institutional Equities sees the sector positioned for strong growth through FY27 with volume recovery and premium segment expansion boosting demand and margins, while stable raw material costs and GST benefits provide a supportive backdrop. Analysts also expect high single‑digit volume growth and improved margins driven by policy tailwinds such as tax reliefs and reforms, which coupled with easing inflation could underpin broader consumption demand. Despite these positive medium‑term fundamentals, FMCG stocks have faced near‑term volatility amid broader market pressures and elevated crude‑linked input costs, with some brokerages highlighting headwinds from sector‑specific shocks such as regulatory and tax changes that have weighed on valuation sentiment and near‑term earnings expectations. These perspectives suggest the sector’s structural growth trajectory remains intact, but the pace and consistency of recovery will depend on how consumption dynamics and cost pressures evolve.
ADVERTISEMENT

IT

The IT sector has faced significant correction, with indices down around 24% year-to-date in 2026 and over 20% year-on-year, driven by AI-led disruption of traditional services models and global macro uncertainty amid West Asian geopolitical tensions, as per ETIG. Analysts have cut target prices for most Tier-I and mid-tier firms by 10–38%. Despite this, ETIG notes that the correction has created selective investment opportunities for companies with steady deal wins, strong order books, and niche AI capabilities. Large-scale reskilling and headcount optimisation will be essential as routine work is automated by AI. Among industry verticals, banking, financial services, and insurance are likely to remain resilient due to continued technology spending, while retail, manufacturing, and travel/transportation remain weak, though telecom is showing early signs of recovery through network modernisation and AI-driven efficiencies. ETIG highlights large-cap players such as Infosys, HCL Technologies, and Tech Mahindra, and mid-tier firms like Coforge and Persistent as well-positioned for FY27.

Commentary from market analysts and brokerages highlights a cautious and mixed outlook for the sector as it navigates subdued demand, AI‑driven disruption, and valuation pressures. Analysts emphasise that industry views are split on long‑term prospects, with firms such as JP Morgan arguing that Indian IT services can continue to play a fundamental role in expanded enterprise AI deployments, while Jefferies projects more restrained earnings growth and potential pressure on services revenue as AI tools improve. Many experts also see valuation compression as a gradual accumulation opportunity, suggesting that IT stocks are trading at multi‑year lows and could offer attractive entry points for long‑term investors. However, broader market context shows that IT stocks have been among the hardest hit in the recent equity downturn, reflecting foreign outflows, AI‑related fears and soft US demand, underlining the near‑term risk and uncertainty around the sector’s earnings and performance. Overall, the consensus from these brokerage and agency viewpoints suggests that while structural growth drivers and selective opportunity remain, the IT sector’s near‑term outlook is cautious and dependent on demand recovery, AI adaptation and macro stabilisation.

Oil & Gas

ETIG expects the oil and gas sector to face mixed outcomes from sharply rising crude prices, which climbed from $66 per barrel in January to around $102 per barrel in March 2026. Upstream companies such as ONGC and Oil India are likely to benefit from stronger price realisations, with margins expanding if operating costs remain stable, whereas oil marketing companies are expected to see compressed margins as gross refining margins are pressured when retail fuel prices do not adjust immediately. Inventory losses, fuel under-recoveries, and higher LPG costs could further weigh on profitability. Sector performance will also depend on government policies such as excise duty adjustments or windfall taxes, while ETIG notes that a return to $60 per barrel crude appears unlikely in the near term. Elevated petroleum prices may additionally push up logistics and packaging costs, influencing both upstream and downstream segments.

Brokerages and credit analysts indicate that India’s oil & gas sector faces a mixed but structurally resilient outlook amid global price volatility and energy security concerns. Ambit Institutional Equities highlights sustained price risk and headwinds for domestic refiners and marketers due to elevated crude prices, while Systematix Institutional Equities forecasts moderate growth in sales, EBITDA, and net profit for oil & gas companies through FY26‑27, supported by stable domestic demand. Credit rating agency analyses from India Ratings project that oil and gas demand will remain robust, helping maintain stable downstream credit profiles, although refining margins may face pressure from global supply fluctuations. Moreover, Reuters‑reported developments around supply disruptions have prompted strategic actions to secure crude supplies and maintain refining throughput, underscoring both the sector’s importance to national energy security and its sensitivity to geopolitical shocks. Overall, the outlook reflects steady demand fundamentals and growth prospects offset by macro volatility, geopolitical pressures, and profit margin challenges in 2026.

Pharma

The pharmaceutical sector is likely to face cost pressures in FY27 as the Iran war disrupts shipping routes and petrochemical supplies, driving up prices of key active pharmaceutical ingredients, solvents, and other raw materials, potentially leading to higher medicine costs or shortages, as per ETIG. It also says that India’s semaglutide market has entered a high-volume, low-margin phase following patent expiry, with therapy costs falling 85-90%, increasing accessibility but resulting in modest earnings gains for most pharma companies due to intense competition and rapid commoditisation. Motilal Oswal Financial Services expects incremental sales improvements in the low single digits from this segment.

Credit rating agencies and sector analysts broadly view the sector as healthy and moderately growing, with external market headwinds. ICRA’s stable sector outlook projects 7-9% revenue growth in FY26, driven by strong domestic demand and European market expansion, while noting that growth in the United States may remain moderate due to pricing pressures and regulatory scrutiny. The agency expects operating profit margins to remain resilient, supported by stable raw material costs and an increasing share of specialty products. Recent cost pressures from global geopolitical tensions, such as rising API and intermediates costs -- underscore near‑term margin headwinds. However, structural demand drivers like deeper rural penetration and expansion of therapy portfolios continue to support medium‑term prospects. Overall, agencies and analysts suggest that the pharma sector’s fundamentals remain strong in 2026, with growth paced by domestic and regulated export markets while near-term risks persist.
Download
The Economic Times Business News App
for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App
for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
READ MORE
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › News › Company › Corporate Trends › Boom or bust? Analysts reveal what lies ahead for India Inc in FY27 amid Iran war
Text Size:AAA
Success
This article has been saved

*

+